10 September, 2017
Saratoga Research & Investment Management sold 15,089 shares as Becton Dickinson & Co (BDX)'s stock rose 1.79%. Becton Dickinson & Co now has $45.13 billion valuation. Lastly, Cowen and Company reissued an "outperform" recommendation and fixed a $230.00 target price (up prior from $200.00) on stocks of Becton, Dickinson and in a study note on early Mon, Jul 10th. The firm has "Buy" rating by Stifel Nicolaus given on Wednesday, November 9. The stock has "Sell" rating by Citigroup on Friday, September 23. BidaskClub cut shares of Becton, Dickinson and from a "strong-buy" rating to a "buy" rating in a research report on Monday, July 31st. RBC Capital Markets maintained Becton Dickinson and Co (NYSE:BDX) on Thursday, August 3 with "Hold" rating. August 10 investment analysts at Barclays maintained a stock rating of "Equal-Weight" but moved up the price target from $158.00 to $210.00. Moreover, Janney Montgomery Scott Ltd Liability Co has 0.08% invested in Becton Dickinson and Co (NYSE:BDX) for 32,926 shares.
Norris Perne & French LLP MI lifted its holdings in shares of Becton, Dickinson and Company (NYSE:BDX) by 25.8% in the second quarter, according to its most recent 13F filing with the SEC. The Saratoga Research & Investment Management holds 227,659 shares with $37.69M value, down from 242,748 last quarter.
Becton, Dickinson and Company (BDX) traded up 0.70% during mid-day trading on Friday, reaching $200.96. Flex Ltd (NASDAQ:FLEX) has risen 35.11% since September 8, 2016 and is uptrending. It has outperformed by 123.85% the S&P500.
Investors sentiment increased to 0.92 in Q4 2016. Its down 0.08, from 1.07 in 2016Q3. It is positive, as 33 investors sold FLEX shares while 120 reduced holdings. 8 funds opened positions while 14 raised stakes. The Company operates through two segments: BD Medical and BD Life Sciences. B & T Dba Alpha reported 13,025 shares. Meyer Handelman holds 326,652 shares or 1.7% of its portfolio. Principal Gp Incorporated holds 0.07% or 313,227 shares. Jarislowsky Fraser Ltd bought 42,722 shares as the company's stock rose 1.79% with the market. Putnam Invs Lc has invested 0% in PACCAR Inc (NASDAQ:PCAR). Bb&T Corporation reported 14,945 shares or 0% of all its holdings. Pioneer Invest reported 0.15% stake. Paradigm Asset Ltd holds 0% or 18,267 shares in its portfolio. Oak Associates Oh accumulated 19,000 shares. Ashfield Cap Prtnrs Lc holds 0.16% of its portfolio in Becton Dickinson and Co (NYSE:BDX) for 9,893 shares. Anson Funds Management Lp, a Texas-based fund reported 131,463 shares.
Among 15 analysts covering Flextronics International Ltd. One analyst has rated the stock with a sell rating, five have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Therefore 73% are positive. RBC Capital Markets maintained Becton Dickinson and Co (NYSE:BDX) on Friday, August 7 with "Sector Perform" rating. H.C. Wainwright maintained it with "Buy" rating and $1800 target in Thursday, June 29 report. The original version of this article can be accessed at https://www.truebluetribune.com/2017/09/08/becton-dickinson-and-company-bdx-position-raised-by-cardinal-capital-management-inc.html. The company was maintained on Monday, August 10 by Deutsche Bank. The rating was initiated by Roth Capital on Friday, July 1 with "Buy". 62,736 are owned by Goldman Sachs. The company was maintained on Monday, January 18 by RBC Capital Markets. The firm has "Overweight" rating by PiperJaffray given on Tuesday, August 9. The firm has "Buy" rating by Jefferies given on Tuesday, July 18.
Mckinley Capital Management Inc decreased Worthington Industries Inc (NYSE:WOR) stake by 39,655 shares to 49,259 valued at $2.34 million in 2016Q4. It also reduced Csra Inc stake by 65,237 shares and now owns 826,933 shares.
More important recent Becton Dickinson and Co (NYSE:BDX) news were published by: Fool.com which released: "Becton, Dickinson results: The raw numbers" on August 09, 2017, also Nasdaq.com published article titled: "Calamos Advisors Llc Buys NextEra Energy Inc, Becton, Dickinson and Co ...", Reuters.com published: "FDA probes possible Becton Dickinson link to faulty lead tests (Aug. 17)" on August 17, 2017. $733,337 worth of stock was sold by Barbier Francois on Tuesday, May 23. It improved, as 5 investors sold Conatus Pharmaceuticals Inc shares while 7 reduced holdings.
Since May 25, 2017, it had 0 insider buys, and 1 sale for $5.35 million activity. About 45,821 shares traded. It has underperformed by 4.38% the S&P500.
Investors sentiment decreased to 0.99 in Q4 2016. Its up 0.02, from 0.9 in 2016Q3. 99 funds opened positions while 273 raised stakes. The dividend payment was $0.730 per share for the quarter which comes to $2.92 on an annualized basis. Concert Wealth Mngmt invested in 3,912 shares or 0.14% of the stock. 246,158 were reported by Douglass Winthrop Advsr Ltd Com. Sigma Planning has 0.13% invested in Becton Dickinson and Co (NYSE:BDX) for 7,115 shares. Following the completion of the transaction, the insider now owns 26,638 shares in the company, valued at approximately $5,279,917.98. Kcg reported 0.11% of its portfolio in Becton Dickinson and Co (NYSE:BDX). Oregon Employees Retirement Fund has invested 0.18% in Becton Dickinson and Co (NYSE:BDX). Of Vermont holds 0% or 271 shares. Middleton And Ma owns 2,888 shares or 0.11% of their U.S. portfolio. Blackrock Fund Advisors owns 49,008 shares or 0% of their USA portfolio. Qci Asset Mgmt Incorporated New York reported 0.01% stake. Rothschild Inv Il reported 2,753 shares stake. Guardian Life Ins Of America accumulated 0.01% or 1,343 shares.
Becton, Dickinson and Company now has a P/E ratio of 58.99 and the market cap of the company is 46.35B. Ironwood Fincl Ltd Limited Liability Company has 0.01% invested in Becton Dickinson and Co (NYSE:BDX) for 100 shares.
Becton, Dickinson and Company is a global medical technology firm engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Exchange Capital Management Inc who had been investing in Chevron Corp for a number of months, seems to be bullish on the $211.86 billion market cap company. It has a 58.15 P/E ratio. BD has almost 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.